BioAge Labs, Inc (NASDAQ:BIOA) — Market Cap & Net Worth
Market Cap & Net Worth: BioAge Labs, Inc (BIOA)
BioAge Labs, Inc (NASDAQ:BIOA) has a market capitalization of $834.63 Million ($834.63 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9877 globally and #2637 in its home market, demonstrating a 26.52% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioAge Labs, Inc's stock price $19.99 by its total outstanding shares 41752472 (41.75 Million). Review BIOA current and long-term liabilities to assess the company's total debt and financial obligations.
BioAge Labs, Inc Market Cap History: 2024 to 2026
BioAge Labs, Inc's market capitalization history from 2024 to 2026. Data shows growth from $241.75 Million to $834.63 Million (5.23% CAGR).
Index Memberships
BioAge Labs, Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.03% | #273 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #1017 of 3165 |
Weight: BioAge Labs, Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
BioAge Labs, Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioAge Labs, Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BIOA by Market Capitalization
Companies near BioAge Labs, Inc in the global market cap rankings as of June 18, 2026.
Key companies related to BioAge Labs, Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #631 globally with a market cap of $43.86 Billion USD ( CN¥299.75 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #634 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.27 |
| #631 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $43.86 Billion | CN¥46.99 |
| #634 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
BioAge Labs, Inc Historical Marketcap From 2024 to 2026
Between 2024 and today, BioAge Labs, Inc's market cap moved from $241.75 Million to $ 834.63 Million, with a yearly change of 5.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $834.63 Million | +51.10% |
| 2025 | $552.39 Million | +128.50% |
| 2024 | $241.75 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of BioAge Labs, Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $834.63 Million USD |
| MoneyControl | $834.63 Million USD |
| MarketWatch | $834.63 Million USD |
| marketcap.company | $834.63 Million USD |
| Reuters | $834.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BioAge Labs, Inc
BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment o… Read more